Literature DB >> 3075461

CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome.

P Youinou1, L Mackenzie, G le Masson, N M Papadopoulos, J Jouquan, Y L Pennec, P Angelidis, P Katsikis, H M Moutsopoulos, P M Lydyard.   

Abstract

CD5, the human counterpart of Ly-1 molecules in the mouse, are detectable but weakly expressed on a minute fraction of circulating B cells. The number of CD5 + B cells in the blood of patients with Sjögren's syndrome was slightly higher than in control blood, but it became statistically significant after treatment of the cells with phorbol myristic acetate. These numbers were even higher in patients with homogeneous serum bands than in the others. A few scattered cells were stained with anti-human IgM antibody on salivary gland sections, and among them 5-10% were found to be positive for anti-CD5.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075461     DOI: 10.1016/0896-8411(88)90025-x

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  19 in total

Review 1.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

2.  Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndrome.

Authors:  R Bataille; X G Zhang; C Duperray; G Rajzbaum; J Brochier; B Klein
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Ocular surface lesions due to keratoconjunctivitis sicca: in primary Sjögren's syndrome.

Authors:  S Roncin; Y L Pennec; P Katsikis; J Colin; P Youinou
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome.

Authors:  E M Deacon; J B Matthews; A J Potts; J Hamburger; R A Mageed; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

5.  Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease.

Authors:  C Bodeutsch; P C de Wilde; L Kater; F H van den Hoogen; R J Hené; J C van Houwelingen; L B van de Putte; G P Vooijs
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

6.  CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis.

Authors:  Jill M Kramer; Ekaterina Klimatcheva; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

7.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

8.  Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.

Authors:  C Jamin; A Lamour; Y L Pennec; M Hirn; P Le Goff; P Youinou
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

Review 9.  B lymphocytes and humoral immune responses in rheumatoid arthritis.

Authors:  L S De Clerck
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

10.  Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.

Authors:  Ben Rowley; Lingjuan Tang; Susan Shinton; Kyoko Hayakawa; Richard R Hardy
Journal:  J Autoimmun       Date:  2007-09-21       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.